Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease

Milos D. Ikonomovic, Elliott J. Mufson, Joanne Wuu, David A. Bennett, Steven T. DeKosky

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background: Cholinergic deficits in the primary visual cortex (PVC) may underlie some of the abnormalities in visual processing and global cognitive performance in Alzheimer's disease (AD). Objective: To correlate measures of general cognition (Mini-Mental State Examination and Global Cognitive Score) and visuospatial function with choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities, and nerve growth factor protein levels in the PVC. Design: The ChAT and AChE enzyme assays and a nerve growth factor protein enzyme-linked immunoabsorbent assay were performed on PVC tissue samples from subjects clinically diagnosed as having mild cognitive impairment (MCI), AD, or no cognitive impairment (NCI). Setting and Patients: Nuns, priests and brothers enrolled in the Religious Order Study, with annual premortem records of neuropsychological testing. Results: Significant differences in ChAT activity, but not in AChE activity or nerve growth factor protein levels, were found among diagnostic groups (P=.049). The ChAT activity was lower in AD than in MCI or NCI (P\.01); MCI was not different from NCI. The PVC ChAT activity correlated with measures of overall cognitive function (Mini-Mental State Examination and Global Cognitive Score), but less so with a composite measure of visuospatial function. Conclusions: The reduction in ChAT activity in the PVC of mild to moderate AD, but not in MCI, might serve to distinguish between clinical and preclinical forms of the disease. It appears that this change relates to generalized cognitive abnormalities but not specifically to visuospatial function.

Original languageEnglish
Pages (from-to)425-430
Number of pages6
JournalArchives of Neurology
Volume62
Issue number3
DOIs
StatePublished - Mar 1 2005
Externally publishedYes

Fingerprint

Choline O-Acetyltransferase
Visual Cortex
Alzheimer Disease
Nerve Growth Factor
Acetylcholinesterase
Cognition
Clergy
Proteins
Enzyme Assays
Cognitive Dysfunction
Alzheimer's Disease
Cortex
Cholinergic Agents
Siblings
Mild Cognitive Impairment
Enzymes
Protein
Nerve
Cognitive Impairment

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease. / Ikonomovic, Milos D.; Mufson, Elliott J.; Wuu, Joanne; Bennett, David A.; DeKosky, Steven T.

In: Archives of Neurology, Vol. 62, No. 3, 01.03.2005, p. 425-430.

Research output: Contribution to journalArticle

Ikonomovic, Milos D. ; Mufson, Elliott J. ; Wuu, Joanne ; Bennett, David A. ; DeKosky, Steven T. / Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease. In: Archives of Neurology. 2005 ; Vol. 62, No. 3. pp. 425-430.
@article{110e0ea7fc7d4215b60b8727d03710ca,
title = "Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease",
abstract = "Background: Cholinergic deficits in the primary visual cortex (PVC) may underlie some of the abnormalities in visual processing and global cognitive performance in Alzheimer's disease (AD). Objective: To correlate measures of general cognition (Mini-Mental State Examination and Global Cognitive Score) and visuospatial function with choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities, and nerve growth factor protein levels in the PVC. Design: The ChAT and AChE enzyme assays and a nerve growth factor protein enzyme-linked immunoabsorbent assay were performed on PVC tissue samples from subjects clinically diagnosed as having mild cognitive impairment (MCI), AD, or no cognitive impairment (NCI). Setting and Patients: Nuns, priests and brothers enrolled in the Religious Order Study, with annual premortem records of neuropsychological testing. Results: Significant differences in ChAT activity, but not in AChE activity or nerve growth factor protein levels, were found among diagnostic groups (P=.049). The ChAT activity was lower in AD than in MCI or NCI (P\.01); MCI was not different from NCI. The PVC ChAT activity correlated with measures of overall cognitive function (Mini-Mental State Examination and Global Cognitive Score), but less so with a composite measure of visuospatial function. Conclusions: The reduction in ChAT activity in the PVC of mild to moderate AD, but not in MCI, might serve to distinguish between clinical and preclinical forms of the disease. It appears that this change relates to generalized cognitive abnormalities but not specifically to visuospatial function.",
author = "Ikonomovic, {Milos D.} and Mufson, {Elliott J.} and Joanne Wuu and Bennett, {David A.} and DeKosky, {Steven T.}",
year = "2005",
month = "3",
day = "1",
doi = "10.1001/archneur.62.3.425",
language = "English",
volume = "62",
pages = "425--430",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease

AU - Ikonomovic, Milos D.

AU - Mufson, Elliott J.

AU - Wuu, Joanne

AU - Bennett, David A.

AU - DeKosky, Steven T.

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Background: Cholinergic deficits in the primary visual cortex (PVC) may underlie some of the abnormalities in visual processing and global cognitive performance in Alzheimer's disease (AD). Objective: To correlate measures of general cognition (Mini-Mental State Examination and Global Cognitive Score) and visuospatial function with choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities, and nerve growth factor protein levels in the PVC. Design: The ChAT and AChE enzyme assays and a nerve growth factor protein enzyme-linked immunoabsorbent assay were performed on PVC tissue samples from subjects clinically diagnosed as having mild cognitive impairment (MCI), AD, or no cognitive impairment (NCI). Setting and Patients: Nuns, priests and brothers enrolled in the Religious Order Study, with annual premortem records of neuropsychological testing. Results: Significant differences in ChAT activity, but not in AChE activity or nerve growth factor protein levels, were found among diagnostic groups (P=.049). The ChAT activity was lower in AD than in MCI or NCI (P\.01); MCI was not different from NCI. The PVC ChAT activity correlated with measures of overall cognitive function (Mini-Mental State Examination and Global Cognitive Score), but less so with a composite measure of visuospatial function. Conclusions: The reduction in ChAT activity in the PVC of mild to moderate AD, but not in MCI, might serve to distinguish between clinical and preclinical forms of the disease. It appears that this change relates to generalized cognitive abnormalities but not specifically to visuospatial function.

AB - Background: Cholinergic deficits in the primary visual cortex (PVC) may underlie some of the abnormalities in visual processing and global cognitive performance in Alzheimer's disease (AD). Objective: To correlate measures of general cognition (Mini-Mental State Examination and Global Cognitive Score) and visuospatial function with choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities, and nerve growth factor protein levels in the PVC. Design: The ChAT and AChE enzyme assays and a nerve growth factor protein enzyme-linked immunoabsorbent assay were performed on PVC tissue samples from subjects clinically diagnosed as having mild cognitive impairment (MCI), AD, or no cognitive impairment (NCI). Setting and Patients: Nuns, priests and brothers enrolled in the Religious Order Study, with annual premortem records of neuropsychological testing. Results: Significant differences in ChAT activity, but not in AChE activity or nerve growth factor protein levels, were found among diagnostic groups (P=.049). The ChAT activity was lower in AD than in MCI or NCI (P\.01); MCI was not different from NCI. The PVC ChAT activity correlated with measures of overall cognitive function (Mini-Mental State Examination and Global Cognitive Score), but less so with a composite measure of visuospatial function. Conclusions: The reduction in ChAT activity in the PVC of mild to moderate AD, but not in MCI, might serve to distinguish between clinical and preclinical forms of the disease. It appears that this change relates to generalized cognitive abnormalities but not specifically to visuospatial function.

UR - http://www.scopus.com/inward/record.url?scp=14844311990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14844311990&partnerID=8YFLogxK

U2 - 10.1001/archneur.62.3.425

DO - 10.1001/archneur.62.3.425

M3 - Article

VL - 62

SP - 425

EP - 430

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 3

ER -